Text and Data Mining valid from 2019-03-21
Received: 24 August 2018
Accepted: 26 February 2019
First Online: 21 March 2019
Ethics approval and consent to participate
: The study was sustained by IMI (Innovative Medicine Initiative) in the grant agreement No 115621 Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies – SPRINTT – and Amendment No 2, 22 May 2015. The study was approved by the Ethical Committee of the Università Cattolica del Sacro Cuore (Protocol Number: 15607/15). The test of the device was included in all SPRINTT ethics approvals. All the participants signed their written informed consent statement in conformity with Italian law and the ethical code of the American Psychological Association.
: Not applicable.
: Caretek s.r.l. is the manufacturer of the ADAMO system. Authors GZ and LF was employed by company Caretek s.r.l. All other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.